These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16081553)

  • 1. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro.
    O'Byrne PM
    Am J Respir Crit Care Med; 2005 Aug; 172(4):410-2; discussion 415-6. PubMed ID: 16081553
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Con.
    Boushey HA
    Am J Respir Crit Care Med; 2005 Aug; 172(4):412-4; discusion 414-5. PubMed ID: 16081554
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroid therapy for asthma: therapeutic and toxic potentials.
    Boushey HA
    Am J Med; 2000 Mar; 108(4):338-40. PubMed ID: 11014728
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability of the combination of formoterol and budesonide in the United States of America.
    Blango CM; O'Brien CD
    Allergy Asthma Proc; 2008; 29(4):426. PubMed ID: 18702893
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
    Pauwels R
    Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 9. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide/formoterol (Symbicort) for asthma.
    Med Lett Drugs Ther; 2008 Feb; 50(1279):9-11. PubMed ID: 18264031
    [No Abstract]   [Full Text] [Related]  

  • 11. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting reliever/preventer inhalers.
    Nurs Times; 2005 Oct 25-31; 101(43):31. PubMed ID: 16276841
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
    Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthma: new insights and advances in treatment].
    Haasler I; Buhl R; Taube C
    Dtsch Med Wochenschr; 2011 Feb; 136(5):198-200. PubMed ID: 21271481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial asthma. Variable treatment promises better control].
    MMW Fortschr Med; 2003 Jul; 145(27-28):65. PubMed ID: 14587201
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled corticosteroids in childhood bronchial asthma.
    Gajanan SG
    Natl Med J India; 1993; 6(2):76-7. PubMed ID: 8477214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.